Get to know IARC researchers! New profile in Portraits of Scientists series
IARC Monographs Meeting 128 to be held remotely
Due to the coronavirus disease (COVID-19) pandemic, IARC Monographs Meeting 128: Acrolein, Crotonaldehyde, and Arecoline, which was scheduled to take...
Genetic markers and breast cancer: Q&A with Dr Zdenko Herceg
Dr Jiri Zavadil presents research at 79th Annual Meeting of Japanese Cancer Association
Dr Jiri Zavadil, the Head of the Molecular Mechanisms and Biomarkers Group at the International Agency for Research on Cancer...
IARC Monographs evaluation of the carcinogenicity of opium consumption
The results of the recent IARC Monographs evaluation of the carcinogenicity of opium consumption have now been published in The...
The neglected environmental impacts of ultra-processed foods
A new Comment published in The Lancet Planetary Health calls for a wider range of factors to be included when...
Breast Cancer Awareness Month 2020
IARC Postdoctoral Fellowships – Call for applications now open
Meeting for IARC Handbooks Volume 18: Cervical Cancer Screening to be held remotely
Get to know IARC researchers!
Report of the Mission Board for Cancer presented to the European Commission
IARC Monographs evaluate the carcinogenicity of opium consumption
Fifth annual World Cancer Research Day: International collaborative research is key for prevention, diagnosis, and treatment of cancer
Genes acting as cancer “drivers” across multiple malignancies revealed
Trans fatty acids from industrial processed foods may be associated with greater risk of developing ovarian cancer
Indoor burning of biomass and kerosene fuels is associated with higher risk of developing several types of digestive cancers
New IARC study on global expansion in overdiagnosis of thyroid cancer
Genetic variant could identify those more susceptible to lung cancer
New estimates highlight the need to step up the response to hepatitis D
Regular use of opium is associated with higher risk of developing a broad array of cancer types
CARCINOGENIC HAZARDS TO HUMANS
TUMOURS (BLUE BOOKS)